Immunara
PrivateCompany Overview
Immunara operates in Healthcare & Life Sciences and is based in San Francisco, California. It was founded in 2026.
Immunara is a biotechnology company that develops an artificial intelligence platform for precision immunology research and immune-mediated disease analysis.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunara Comparables
Compare Immunara with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scienta Lab | 87% | |
| Immunai | 83% | |
| Relation Therapeutics | 81% |
For institutional investors. Book with your work email.
Immunara Funding Rounds
Historical fundraising activity
Immunara Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Immunara's valuation, stock price, and market status.
Is Immunara a public or private company?
Immunara is a private company.
What is the current stock price of Immunara?
Immunara is a private company, so its shares have no public market price. Caplight tracks Immunara's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Immunara worth (valuation)?
Valuation information for Immunara is not publicly available.
Can I buy Immunara stock?
Immunara shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Immunara's last funding round?
Funding round information for Immunara is not publicly available.
Who are the main investors in Immunara?
Investor information for Immunara is not publicly disclosed.
Will Immunara IPO soon?
No public IPO plans have been announced for Immunara.
How can I track Immunara secondary market activity?
Caplight tracks bids, offers, and trades in Immunara's shares on secondary markets.